Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1977 May;39(5):1936-9.
doi: 10.1002/1097-0142(197705)39:5<1936::aid-cncr2820390504>3.0.co;2-n.

5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases

J S Link, J R Bateman, W S Paroly, W J Durkin, R L Peters
Clinical Trial

5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases

J S Link et al. Cancer. 1977 May.

Abstract

Twenty-one patients with biopsy-proven hepatocellular carcinoma were treated with oral or intravenous 5-Fluorouracil according to a randomized treatment schedule. Twenty-one patients were evaluable for response and toxicity. The two groups were comparable in distribution of pretreatment characteristics. There were no objective responses in either group. This is the largest reported group of patients with hepatocellular carcinoma treated with 5-Fluorouracil. Toxicity occurred in 46% of patients treated, but was tolerable. In contrast to previous reports, we have found that weekly 5-Fluorouracil given orally or intravenously is not of significant value in the treatment of hepatocellular carcinoma.

PubMed Disclaimer

Publication types